Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats

Acta Pharmacologica Sinica

Volumn 21, Issue 7, 2000, Pages 613-616

  Pan, Guo Yu ^a   Liu, Xiao Dong ^a   Liu, Guo Qing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Mannitol; Methotrexate

Indexed keywords

MANNITOL; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG PENETRATION; INTERNAL CAROTID ARTERY; NONHUMAN; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CAROTID ARTERY, INTERNAL; CEREBRAL CORTEX; FEMALE; HYPERTONIC SOLUTIONS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MANNITOL; METHOTREXATE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033911807     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 3H]Methotrexate loss from the rat following enhanced uptake by osmotic opening of the blood-brain barrier. Cancer Res 1985; 45: 1092-6.
2. Hasegawa H, Allen JC, Mehta BM, Shapiro WR, Posner JB. Enhancement of CNS penetration of methotrexate by hypertonic intracarotid mannitol or carcinomatous meningitis. Neurology 1979; 29: 1280-6.
3. Culver B, Inzana K, Jones J, Troy G, Kroll R, Culver B, et al. Technique of, and complications attribute to, repeated hyperosmotic blood-barrier disruption in dogs. Am J Vet Res 1998; 59; 11: 1503-10.
4. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurons only after blood-brain barrier disruption. Br J Pharmacol 1993; 109: 788-92.
5. Chen XM, Wang R, Xu RL, Yi L, Zhao YC, Ma YH, et al. A method to determine water content in brain. Chin J Pathophysiol 1992; 8: 301-2.
6. Zhang XG, Liu QL, Pu L, Wu DZ. A simple fluorometric method for determines methotrexate in serum and urine. Chin Pharm Bull 1983; 18: 514-6.
7. Sogabe T, Miura I. 31P-NMR studies on time-course of change in the blood-brain barrier after treatment with hypertonic solution. Biochim Biophys Acta 1990; 1051: 282-4.
8. Wang ZY, Wang Y, Yi SY. Enhancement of MIX entering the brain by osmotic opening the BBB. Cancer Res Prev Treat 1987; 14: 65-6.
9. Warkentin P, Coccia P, Ramsay N, Nesbit M, Krivit W. Acute hepatocellular injury after high doses methotrexate infusions. Proc Am Soc Clin Oncol 1978; 19: 337.
10. Goh TS, Wong KY, Lampoon B, O'Leary J, Gnarr D. Evaluation of 24-hour infusion of high-dose methotrexate pharmacokinetics and toxicity. Cancer Chemother Pharmacol 1979; 3: 177-80.
11. Wang YM, Fujimoto T. Clinical pharmacokinetics of methotrexate in children. Clin Pharmocokinet 1984; 9: 335-48.
12. Osomoff HL. Distribution of intracranial contents after hypertonic urea. J Neurosurg 1992; 19: 859-64.
13. Vorbrodt AW, Lossinsky AS, Dobrogowska DH, Wisniewski HM. Cellular mechanisms of the blood-brain barrier (BBB) opening to albumin-gold complex. Histol Histopathol 1993; 8: 56-61.
14. Hardebo JE, Nilsson B. Hemodynamic changes in brain caused by local infusion of hypertonic solutions, in particular relation to blood-brain barrier opening. Brain Res 1980; 181: 49-59.
15. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery 1999; 44: 1055-63.